REVIEW

Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and ß cell failure

J R Porter, T G Barrett

Birmingham Children’s Hospital, Birmingham, UK

Correspondence to:
Dr John R Porter
Diabetes Homecare Unit, Birmingham Children’s Hospital, Steelhouse Lane, Birmingham B4 6NH, UK; j.porter{at}bham.ac.uk

Type 2 diabetes mellitus is caused by a combination of insulin resistance and ß cell failure. The polygenic nature of type 2 diabetes has made it difficult to study. Although many candidate genes for this condition have been suggested, in most cases association studies have been equivocal. Monogenic forms of diabetes have now been studied extensively, and the genetic basis of many of these syndromes has been elucidated, leading to greater understanding of the functions of the genes involved. Common variations in the genes causing monogenic disorders have been associated with susceptibility to type 2 diabetes in several populations and explain some of the linkage seen in genome-wide scans. Monogenic disorders are also helpful in understanding both normal and disordered glucose and insulin metabolism. Three main areas of defect contribute to diabetes: defects in insulin signalling leading to insulin resistance; defects of insulin secretion leading to hypoinsulinaemia; and apoptosis leading to decreased ß cell mass. These three pathological pathways are reviewed, focusing on rare genetic syndromes which have diabetes as a prominent feature. Apoptosis seems to be a final common pathway in both type 1 and type 2 diabetes. Study of rare forms of diabetes may help ion determining new therapeutic targets to preserve or increase ß cell mass and function.

Abbreviations: BSCL, Berardinelli–Seip congenital lipodystrophy; FARR, Friedreich’s ataxia with retained lower limb reflexes; FFA, free fatty acids; GSIR, glucose stimulated insulin release; LOFA, late onset Friedreich’s ataxia; MODY, maturity onset diabetes of the young; PERK, pancreatic endoplasmic reticulum kinase; PPAR, peroxisome proliferator activated receptor ; RMS, Rabson–Mendenhall syndrome; TNDM, transient neonatal diabetes; TRMA, thiamine responsive megaloblastic anaemia

Keywords: diabetes; monogenic disorder; genetics; ß cell apoptosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Sookoian, S., Pirola, C. J. (2007). Review: Genetics of the cardiometabolic syndrome: new insights and therapeutic implications. Ther Adv Cardiovasc Dis 1: 37-47 [Abstract]  
• Yamada, T., Ishihara, H., Tamura, A., Takahashi, R., Yamaguchi, S., Takei, D., Tokita, A., Satake, C., Tashiro, F., Katagiri, H., Aburatani, H., Miyazaki, J.-i., Oka, Y. (2006). WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic {beta}-cells. Hum Mol Genet 15: 1600-1609 [Abstract] [Full Text]